MORGAN STANLEY - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTXTQ and the CUSIP is 71426V306. A total of 33 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q2 2017. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q4 2018$4,000
+100.0%
10,782
+420.6%
0.00%
Q3 2018$2,000
-75.0%
2,071
-37.5%
0.00%
Q2 2018$8,000
+60.0%
3,311
+58.5%
0.00%
Q1 2018$5,000
-85.3%
2,089
-85.3%
0.00%
Q4 2017$34,000
-50.7%
14,209
-34.5%
0.00%
Q3 2017$69,000
-35.5%
21,694
-18.5%
0.00%
Q2 2017$107,000
+143.2%
26,618
+120.9%
0.00%
Q1 2017$44,000
+57.1%
12,052
-9.1%
0.00%
Q4 2016$28,00013,2520.00%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q2 2017
NameSharesValueWeighting ↓
Aisling Capital LLC 210,000$777,0000.14%
SEARLE & CO. 17,250$64,0000.04%
Jefferies Group LLC 259,200$959,0000.01%
Renaissance Technologies 740,650$2,740,0000.00%
Virtu KCG Holdings LLC 28,739$106,0000.00%
GROUP ONE TRADING, L.P. 19,945$74,0000.00%
SIMPLEX TRADING, LLC 4,950$18,0000.00%
IFP Advisors, Inc 427$2,0000.00%
Advisor Group, Inc. 177$1,0000.00%
BANK OF AMERICA CORP /DE/ 8,363$31,0000.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders